Poly Medicure Limited's Audit Committee reviewed the utilization of funds from its Qualified Institutions Placement (QIP), which raised approximately 1,000 Cr by allotting 53.19 lakh equity shares at Rs 1,880 each. For the quarter ended June 30, 2025, the company reported no deviation or variation from the original objects of the issue, which included funding capital expenditure, pursuing inorganic initiatives, and general corporate purposes. A small surplus of 0.34 Cr from issue expenses was reallocated to general corporate purposes. This update confirms the company is deploying the QIP proceeds as planned, providing transparency to investors.